Intraperitoneal Ropivacaine Nebulization for Pain Control After Laparoscopic Surgery
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if intraperitoneal nebulization of Ropivacaine 50 mg,
100 mg or 150 mg may prevent the use of morphine during the first day after laparoscopic
cholecystectomy.
Phase:
Phase 3
Details
Lead Sponsor:
San Gerardo Hospital
Collaborators:
Azienda L'ULSS 15 Alta Padovana Azienda U.S.L. della Valle d'Aosta, Ospedale Regionale Umberto Parini Gruppo Ospedaliero San Donato, Policlinico San Pietro, Ponte San Pietro, Bergamo IRCCS Policlinico S. Matteo University of Milano Bicocca